1. Articles in category: Epidemiology

    1-6 of 6
    1. Risk of Childhood Cancer by Maternal Birthplace: A Test of the Hispanic Paradox.

      Risk of Childhood Cancer by Maternal Birthplace: A Test of the Hispanic Paradox.

      JAMA Pediatr. 2016 Apr 25;

      Authors: Heck JE, Park AS, Contreras ZA, Davidson TB, Hoggatt KJ, Cockburn M, Ritz B

      Abstract Importance: The Hispanic epidemiologic paradox is the phenomenon that non-US-born Hispanic mothers who immigrate to the United States have better pregnancy outcomes than their US-born counterparts. It is unknown whether this advantage extends to childhood cancer risk.

      Read Full Article
    2. Current Management of Neonatal Neuroblastoma.

      "The epidemiology of neonatal (age less than 30 days) neuroblastoma contrasts greatly with patients older than 30 days. Owing to the unique potential for spontaneous regression of this tumor type, several groups have sought to reduce therapy given to neonates with neuroblastoma and use a watch-and-wait approach for many low-risk patients. Ongoing studies also seek to reduce therapy for some intermediate-risk patients in an attempt to lessen exposure to surgical intervention and cytotoxic chemotherapy. In this review, we discuss the epidemiology, clinical presentation, staging, and treatment for neonates with neuroblastoma."

      Read Full Article
      Mentions: Surgery
    3. Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients

      Diarrhea is a common problem in the pediatric population. Children with cancer are especially at increased risk for gastrointestinal infection-related morbidity and mortality due to their ongoing immunosuppression. However, the epidemiology of diarrheal illnesses in immunocompromised children is poorly understood.

      Read Full Article
    4. Why infection may cause childhood leukaemia – and prevent it

      A new study helps explain why early infection and vaccination could protect children against leukaemia – while later infection could raise the risk. Infectious diseases like smallpox, polio and tuberculosis used to cause huge amounts of death and disability across the world, but the advent of vaccination has all but wiped out them out. Immunisation is one of the great successes of modern medicine and has helped to protect millions of lives.

      Read Full Article
    5. Conditional survival in pediatric malignancies: Analysis of data from the Childhood Cancer Survivor Study and the Surveillance, Epidemiology, and End Results Program - Mertens - 2014 - Cancer

      "The risk of death among survivors of pediatric cancer in 10 years can vary between diagnosis groups by at most 12%, even up to 20 years after diagnosis. This information is clinically significant when counseling patients regarding their conditional survival, particularly when survivors are seen in long-term follow-up."

      Read Full Article
    6. Use of patient registries and administrative datasets for the study of pediatric cancer.

      Use of patient registries and administrative datasets for the study of pediatric cancer.

      "Analysis of data from large administrative databases and patient registries is increasingly being used to study childhood cancer care, although the value of these data sources remains unclear to many clinicians. Interpretation of large databases requires a thorough understanding of how the dataset was designed, how data were collected, and how to assess data quality. This review will detail the role of administrative databases and registry databases for the study of childhood cancer, tools to maximize information from these datasets, and recommendations to improve the use of these databases for the study of pediatric oncology."

      Read Full Article
      Mentions: Surgery
    1-6 of 6
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Drug Development, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles